University of Cambridge

The Karadottir lab’s interests are neurotransmitter signalling to oligodendrocytes and their progenitor cells, in both health and disease. Oligodendrocytes produce myelin (in the CNS), which speeds the propagation of the action potential. When the myelin sheath is lost or not formed, in diseases like cerebral palsy, spinal cord injury and multiple sclerosis, it causes mental and physical disability. We study how oligodendrocytes respond to neurotransmitters released from axons, both in the normal brain and in pathological conditions.

Read more

Synapses lost and found in brain development, disease and repair

by Carla Shatz

Sapp Family Provostial Professor
Professor of Biology and Neurobiology
David Starr Jordan Director, Stanford Bio-X
James H. Clark Center, Stanford, USA

The lecture will be followed by a reception (ON2 entrance hall)

Dr. Shatz’s research aims to understand how early developing brain circuits are transformed into adult connections during critical periods of development. Her work, which focuses on the development of the mammalian visual system, has relevance not only for treating disorders such as autism and schizophrenia, but also for understanding how the nervous and immune systems interact. Dr. Shatz graduated from Radcliffe College in 1969 with a B.A. in Chemistry. She was honored with a Marshall Scholarship to study at University College London, where she received an M.Phil. in Physiology in 1971. In 1976, she was the first woman to receive a Ph.D. in Neurobiology from Harvard Medical School, where she studied with Nobel Laureates David Hubel and Torsten Wiesel. During this period, she was appointed as a Harvard Junior Fellow. From 1976 to 1978 she obtained postdoctoral training with Dr. Pasko Rakic in the Department of Neuroscience, Harvard Medical School. In 1978, Dr. Shatz moved to Stanford University, where she attained the rank of Professor of Neurobiology in 1989. In 1992, she moved her laboratory to the University of California, Berkeley as Professor of Neurobiology and an Investigator of the Howard Hughes Medical Institute. From 2000-2007 she was Chair of the Department of Neurobiology at Harvard Medical School and the Nathan Marsh Pusey Professor of Neurobiology. In recognition of her contributions, in 1992, she was elected to the American Academy of Arts and Sciences, in 1995 to the National Academy of Sciences, in 1997 to the American Philosophical Society, in 1999 to the Institute of Medicine, and in 2011 she was elected a Foreign Member of the Royal Society of London. Among her many awards, Dr. Shatz received the Gerard Prize in Neuroscience in 2011 from the 40,000 member Society for Neuroscience, and in 2015, the Gruber Prize in Neuroscience. In 2016, she was the recipient of the Champalimaud Vision Prize, and the Kavli Prize in Neuroscience for the discovery of mechanisms that allow experience and neural activity to remodel brain circuits. Most recently (2018) she received the Harvey Prize in Science and Technology from the Technion Israel Institute of Technology.